Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 14 | 2024 | 1959 | 2.000 |
Why?
|
| Doxorubicin | 6 | 2022 | 2224 | 1.230 |
Why?
|
| Hyaluronic Acid | 3 | 2020 | 484 | 1.120 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2020 | 620 | 1.070 |
Why?
|
| Copper | 4 | 2020 | 365 | 0.970 |
Why?
|
| Sulfides | 3 | 2021 | 168 | 0.930 |
Why?
|
| Hyperthermia, Induced | 3 | 2021 | 417 | 0.810 |
Why?
|
| Neoplasms | 11 | 2024 | 22140 | 0.770 |
Why?
|
| Phototherapy | 6 | 2021 | 368 | 0.710 |
Why?
|
| Photochemotherapy | 4 | 2020 | 826 | 0.680 |
Why?
|
| Polylysine | 1 | 2020 | 131 | 0.680 |
Why?
|
| Triterpenes | 1 | 2020 | 76 | 0.680 |
Why?
|
| Metal Nanoparticles | 2 | 2020 | 400 | 0.650 |
Why?
|
| Nanostructures | 1 | 2022 | 551 | 0.580 |
Why?
|
| Drug Delivery Systems | 6 | 2022 | 2223 | 0.570 |
Why?
|
| Cancer Vaccines | 1 | 2024 | 1038 | 0.550 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 677 | 0.540 |
Why?
|
| Silicon Dioxide | 6 | 2022 | 216 | 0.500 |
Why?
|
| Paclitaxel | 2 | 2020 | 1730 | 0.450 |
Why?
|
| Antineoplastic Agents | 9 | 2022 | 13632 | 0.390 |
Why?
|
| Polymers | 1 | 2019 | 1617 | 0.390 |
Why?
|
| Cell Membrane | 1 | 2020 | 3661 | 0.370 |
Why?
|
| Apoptosis | 9 | 2022 | 9477 | 0.360 |
Why?
|
| Graphite | 3 | 2020 | 77 | 0.360 |
Why?
|
| Mice, Inbred BALB C | 6 | 2020 | 6199 | 0.350 |
Why?
|
| Cell Line, Tumor | 11 | 2022 | 16952 | 0.330 |
Why?
|
| Macrophages | 2 | 2021 | 5753 | 0.320 |
Why?
|
| Mice, Nude | 5 | 2020 | 3605 | 0.300 |
Why?
|
| Tissue Distribution | 3 | 2021 | 2263 | 0.300 |
Why?
|
| Liposomes | 3 | 2020 | 783 | 0.290 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 4021 | 0.240 |
Why?
|
| Drug Carriers | 4 | 2022 | 705 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2021 | 2138 | 0.220 |
Why?
|
| Cell Proliferation | 6 | 2021 | 10422 | 0.210 |
Why?
|
| Drug Compounding | 2 | 2021 | 245 | 0.200 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 3873 | 0.200 |
Why?
|
| Nanoshells | 1 | 2021 | 11 | 0.190 |
Why?
|
| Bismuth | 1 | 2021 | 29 | 0.190 |
Why?
|
| Titanium | 2 | 2020 | 490 | 0.180 |
Why?
|
| Immunotherapy | 5 | 2024 | 4642 | 0.170 |
Why?
|
| Aerosols | 2 | 2022 | 635 | 0.170 |
Why?
|
| Phytosterols | 1 | 2020 | 55 | 0.170 |
Why?
|
| Silver | 1 | 2020 | 117 | 0.170 |
Why?
|
| Nanocapsules | 1 | 2021 | 94 | 0.170 |
Why?
|
| Animals | 17 | 2024 | 168079 | 0.170 |
Why?
|
| Photosensitizing Agents | 2 | 2021 | 625 | 0.170 |
Why?
|
| Prostatic Neoplasms | 2 | 2019 | 11101 | 0.170 |
Why?
|
| Infrared Rays | 1 | 2020 | 248 | 0.160 |
Why?
|
| Indocyanine Green | 1 | 2021 | 234 | 0.160 |
Why?
|
| Ferrocyanides | 1 | 2018 | 3 | 0.160 |
Why?
|
| Nanotechnology | 1 | 2024 | 713 | 0.160 |
Why?
|
| Receptors, Somatostatin | 1 | 2019 | 137 | 0.150 |
Why?
|
| Palladium | 1 | 2018 | 67 | 0.150 |
Why?
|
| Nanomedicine | 1 | 2020 | 289 | 0.150 |
Why?
|
| Somatostatin | 1 | 2019 | 447 | 0.140 |
Why?
|
| Peptides, Cyclic | 1 | 2019 | 392 | 0.140 |
Why?
|
| Gold | 1 | 2021 | 482 | 0.140 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 20982 | 0.130 |
Why?
|
| Carbon | 1 | 2019 | 665 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2022 | 900 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 3092 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3592 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2227 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 6124 | 0.100 |
Why?
|
| Mice | 8 | 2021 | 81326 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8519 | 0.090 |
Why?
|
| Particle Size | 3 | 2020 | 1649 | 0.090 |
Why?
|
| Humans | 18 | 2024 | 761208 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 1535 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2021 | 3551 | 0.070 |
Why?
|
| Mitochondria | 1 | 2021 | 3620 | 0.070 |
Why?
|
| Peptides | 1 | 2019 | 4353 | 0.070 |
Why?
|
| Surface Properties | 2 | 2021 | 1162 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2021 | 2477 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2021 | 3406 | 0.060 |
Why?
|
| Melanoma | 1 | 2021 | 5694 | 0.050 |
Why?
|
| HT29 Cells | 1 | 2020 | 192 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2019 | 2925 | 0.040 |
Why?
|
| Oximes | 1 | 2021 | 303 | 0.040 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 296 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 405 | 0.040 |
Why?
|
| Cell Membrane Permeability | 1 | 2021 | 573 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2019 | 161 | 0.040 |
Why?
|
| Topotecan | 1 | 2019 | 131 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 575 | 0.040 |
Why?
|
| Static Electricity | 1 | 2019 | 260 | 0.040 |
Why?
|
| Porosity | 1 | 2019 | 348 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22127 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2019 | 598 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1351 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2018 | 714 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2021 | 1525 | 0.030 |
Why?
|
| Imidazoles | 1 | 2021 | 1172 | 0.030 |
Why?
|
| Female | 4 | 2020 | 392544 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 1187 | 0.030 |
Why?
|
| Drug Design | 1 | 2018 | 1045 | 0.030 |
Why?
|
| Aorta | 1 | 2021 | 2040 | 0.030 |
Why?
|
| Light | 1 | 2018 | 1348 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2018 | 1594 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 1703 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2022 | 3048 | 0.020 |
Why?
|
| Indoles | 1 | 2018 | 1830 | 0.020 |
Why?
|
| Male | 4 | 2021 | 360693 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2813 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 8164 | 0.020 |
Why?
|
| Cell Survival | 1 | 2018 | 5778 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2018 | 2726 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4574 | 0.010 |
Why?
|
| Rats | 1 | 2020 | 23704 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2018 | 3758 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 18220 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11733 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13385 | 0.010 |
Why?
|
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_